Adipose Tissue Plasticity During Catch-Up Fat Driven by Thrifty Metabolism: Relevance for Muscle-Adipose Glucose Redistribution During Catch-Up Growth by Summermatter, Serge et al.
Adipose Tissue Plasticity During Catch-Up Fat Driven by
Thrifty Metabolism
Relevance for Muscle-Adipose Glucose Redistribution
During Catch-Up Growth
Serge Summermatter,
1 Helena Marcelino,
1 Denis Arsenijevic,
1 Antony Buchala,
2 Olivier Aprikian,
3
Franc ¸oise Assimacopoulos-Jeannet,
4 Josiane Seydoux,
5 Jean-Pierre Montani,
1 Giovanni Solinas,
1
and Abdul G. Dulloo
1
OBJECTIVE—Catch-up growth, a risk factor for later type 2
diabetes, is characterized by hyperinsulinemia, accelerated body-
fat recovery (catch-up fat), and enhanced glucose utilization in
adipose tissue. Our objective was to characterize the determi-
nants of enhanced glucose utilization in adipose tissue during
catch-up fat.
RESEARCH DESIGN AND METHODS—White adipose tissue
morphometry, lipogenic capacity, fatty acid composition, insulin
signaling, in vivo glucose homeostasis, and insulinemic response
to glucose were assessed in a rat model of semistarvation-
refeeding. This model is characterized by glucose redistribution
from skeletal muscle to adipose tissue during catch-up fat that
results solely from suppressed thermogenesis (i.e., without
hyperphagia).
RESULTS—Adipose tissue recovery during the dynamic phase
of catch-up fat is accompanied by increased adipocyte number
with smaller diameter, increased expression of genes for adipo-
genesis and de novo lipogenesis, increased fatty acid synthase
activity, increased proportion of saturated fatty acids in triglyc-
eride (storage) fraction but not in phospholipid (membrane)
fraction, and no impairment in insulin signaling. Furthermore, it
is shown that hyperinsulinemia and enhanced adipose tissue de
novo lipogenesis occur concomitantly and are very early events
in catch-up fat.
CONCLUSIONS—These ﬁndings suggest that increased adi-
pose tissue insulin stimulation and consequential increase in
intracellular glucose ﬂux play an important role in initiating
catch-up fat. Once activated, the machinery for lipogenesis and
adipogenesis contribute to sustain an increased insulin-stimu-
lated glucose ﬂux toward fat storage. Such adipose tissue plas-
ticity could play an active role in the thrifty metabolism that
underlies glucose redistribution from skeletal muscle to adipose
tissue. Diabetes 58:2228–2237, 2009
T
he pattern of growth early in life is now recog-
nized to be an important predictor of chronic
metabolic diseases. In particular, people who
had low birth weight or whose growth faltered
during infancy and childhood, but who subsequently
showed catch-up growth, had higher propensity for the
development of abdominal obesity, type 2 diabetes, and
cardiovascular diseases later in life (1–8). The mechanistic
basis of the link between catch-up growth and risks for
these chronic diseases is poorly understood. There is,
however, compelling evidence that mammalian catch-up
growth is characterized by a disproportionately higher rate
of body fat than lean tissue gain (9) and that an early
feature of such “preferential catch-up fat” is concomitant
hyperinsulinemia (10).
Using a rat model of semistarvation-refeeding (11), in
which catch-up fat is studied in the absence of hyperpha-
gia, we previously showed that the hyperinsulinemic state
of catch-up fat preceded the development of excess adi-
posity and could be linked to suppressed thermogenesis,
per se, in the absence of hyperphagia (12). Subsequent
studies of hyperinsulinemic-euglycemic clamps during
catch-up fat showed that in vivo insulin-mediated glucose
utilization was diminished in skeletal muscle but enhanced
in white adipose tissue (WAT), suggesting that preferential
catch-up fat is characterized by glucose redistribution
from skeletal muscle to WAT (13). Consistent with this
hypothesis are the demonstrations, in this rat model of
catch-up fat, of diminished mitochondrial mass and lower
insulin receptor substrate (IRS)-1–associated phosphati-
dylinositol-3-kinase (PI3K) activity in the skeletal muscle
(14,15). Furthermore, ex vivo studies in WAT have previ-
ously shown that glucose uptake and utilization are en-
hanced during refeeding after fasting or caloric restriction
(16,17).
Elucidating the mechanisms that underlie such enhance-
ment in glucose uptake and glucose ﬂux toward lipid
synthesis in WAT is therefore of central importance in
understanding the mechanisms of glucose redistribution
during catch-up fat. In addressing this topic, we have
characterized our rat model of catch-up fat for changes in
adipose tissue morphometry (adipocyte size and number)
and fatty acid composition given their importance as
determinants of WAT responsiveness to the action of
insulin on glucose utilization. Indeed, it is established that
small adipocytes have a greater capacity for insulin-
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larger ones (18–22), while alterations in adipocyte mem-
brane phospholipid composition in favor of a high ratio of
polyunsaturated fatty acids (PUFAs) to saturated fatty
acids (SFAs) correlates with increased rate of insulin-
stimulated glucose transport and glucose ﬂux toward de
novo lipogenesis in WAT (23–24). We have therefore
investigated here the extent to which differences in adipo-
cyte number and diameter, key gene markers for adipo-
cyte proliferation, as well as the fatty acid composition of
phospholipid and triglyceride lipid fractions of WAT,
might be involved in the enhanced glucose ﬂux toward
lipogenesis. Furthermore, given the importance of insulin
signaling in adipocyte growth (25) and in controlling
glucose ﬂux toward lipogenesis (26,27), we have also
evaluated the in vivo insulinemic response to glucose
and investigated proximal insulin signaling in WAT
under basal and in vivo insulin-stimulated conditions
during catch-up fat.
RESEARCH DESIGN AND METHODS
Male Sprague-Dawley rats (Elevage Janvier, Le Genest Saint-Isle, France),
caged singly in a temperature-controlled room (22  1°C) with a 12-h
light/dark cycle, were maintained on a commercial standard diet (Kliba,
Cossonay, Switzerland), consisting, by energy, of 24% protein, 66% carbohy-
drates, and 10% fat, and had free access to tap water. Animals were maintained
in accordance with our institute’s regulations and guide for the care and use
of laboratory animals.
The experiments were performed in rats within an age range characterized
by high rate of growth for controls and by catch-up growth in the refed group
during ad libitum access to food (online appendix [available at http://diabetes.
diabetesjournals.org/cgi/content/full/db08-1793/DC1]). The experimental de-
sign is similar to that previously described in establishing a rat model for studying
changes in energy expenditure that occur during accelerated fat deposition (i.e.,
catch-up fat) upon refeeding after growth arrest (11,12) (i.e., an approach that
allows suppressed thermogenesis speciﬁc for accelerated fat recovery [catch-up
fat] to be studied in the absence of confounding variables such food intake and
differential rates of protein gain) on energy expenditure. In brief, groups of
7-week-old rats (mean body weight of 225 g) are food restricted at 50% of their
spontaneous food intake for 2 weeks. After this period of growth arrest, they are
refed the same standard diet at a level equal in metabolizable energy content to
the spontaneous food intake of control rats matched for weight at the onset of
refeeding. Under these conditions, the refed animals show similar gain in lean
mass but about twofold increase in body fat gain than controls for a period of 2
weeks, due to 10–13% lower energy expenditure resulting from suppressed
thermogenesis (11,12).
Body composition. Body composition was determined at the end of semi-
starvation (corresponding to day 0 of refeeding) and subsequently on days 5,
10, 15, and 20 of refeeding in refed and control groups, as indicated in Fig. 1.
After the animals were killed, the whole carcasses were dried to a constant
weight in an oven maintained at 70°C and subsequently homogenized for
analysis of fat content by the Soxhlet extraction method as previously
described (11); the dry lean body mass (a proxy of protein mass) was
determined by subtracting total body fat and body water content from body
weight.
Glucose tolerance test. Intraperitoneal glucose tolerance test (GTT) was
performed as previously described (12). Plasma glucose was determined using
a Beckman glucose analyzer (Beckman Instruments, Palo Alto, CA), while
plasma insulin was assessed using a rat insulin enzyme-linked immunosorbent
assay kit (Crystal Chem, Downers Grove, IL).
Adipocyte number and size. Fixation with osmium tetroxide and isolation
of adipocytes for cell counting/sizing were performed according to the method
of Hirsch and Gallian (28), and suspensions of adipocytes were analyzed using
Multisizer 3 Coulter Counter. For determination of cell size (adipocyte
diameter distribution), similar amounts of cells (10,000) were aspirated by
the machine and classiﬁed according to their diameter and frequency.
Molecular measurements and lipid biochemistry. After harvesting, the
adipose tissue was snap frozen in liquid nitrogen and stored at 80°C. Total
RNA was isolated from 50 to 150 mg of powdered adipose tissue using the
method of Chomczynski and Sacchi (29). After phase separation, RNA was
precipitated with isopropanol, cDNA was synthesized from 250 ng of total
RNA, and RT-PCR was performed. Cyclophilin was used as an invariant
control since we found that its mRNA levels in WAT are not signiﬁcantly
altered in response to semistarvation or to refeeding in our rat model. The
relative quantiﬁcation for a given gene was thus corrected for the cyclophilin
mRNA values.
Fatty acid synthase (FAS) activity was measured according to the protocol
described by Pe ´nicaud et al. (30). For fatty acid proﬁling, equal amounts of
tissue samples were suspended (1:2:0.8, vol/vol/vol), vortexed, and incubated
for 10 min at room temperature. Lipids were extracted using the method of
Bligh and Dyer (31), and the fatty acid methyl esters were prepared as
described by Morrison and Smith (32) and were analyzed by gas chromatog-
raphy/mass spectrometry as detailed previously (33).
For PI3K assay, 200–500 mg of protein extract was immunoprecipitated
with IRS-1 (Upstate) polyclonal antibody. The kinase reaction, thin-layer
chromatography separation, and signal detection were performed as previ-
ously described (15,34). Akt (Ser473) and extracellular signal–regulated
kinase (ERK) (p44/42 mitogen-activated protein kinase) were evaluated by
immunoblot analysis. A total of 40 g of protein extract were separated by
SDS-PAGE and blotted on polyvinylidene ﬂuoride membranes that were
analyzed with polyclonal antibodies (Cell Signaling) raised against the indi-
cated phosphorylation sites. Bands within the linear range were quantiﬁed
densitometrically. Total protein amount of Akt and ERK were measured in the
same way by using corresponding antibodies (Cell Signaling).
In vivo bolus administration of insulin. The rats were fasted from 0700 h,
and 4–7 h later subgroups were anesthetized by injection of ketamine/xylazine
(39/5 mg/kg body wt) and surgically prepared for a bolus injection (through
the jugular vein) of insulin (10 units/kg body wt) (Actrapid; Novo Nordisk) or
an equal volume of saline vehicle. Insulin or saline was injected 3 min before
rats were killed and the tissue was harvested. Immediately after the rats were
killed, the epididymal adipose tissue as well as skeletal muscles were rapidly
dissected, frozen in liquid nitrogen, and stored at 80°C until analysis. The
timing for tissue harvesting after hormonal administration, and the dose of
insulin utilized, correspond to maximal activation of PI3K assessed in
preliminary studies and are consistent with those obtained by others (35).
Data analysis and statistics. All data are presented as means  SE. Direct
comparisons between the two groups were performed using unpaired t tests.
Between-group differences in distribution curves for adipocyte diameter were
analyzed by the Kolmogorov-Smirnov test, which takes into account the
ordering (i.e., cell diameter) of the categories and is therefore a suitable test
for analysis of curve shifts. Between-group differences across time were
analyzed by regression analysis incorporating between-group comparison of
slopes. For the study comparing refed and control animals in response to
hormone or saline, the data were analyzed by two-factor ANOVA for the main
effects of groups (refed versus control), treatment (hormone versus saline),
and group-times-treatment interactions. All statistical treatment of data were
performed using the computer software STATISTIX 8 (Analytical Software,
Tallahassee, FL).
RESULTS
Body composition and GTT. In this rat model of
catch-up fat, the end of semistarvation (or onset of refeed-
ing) is characterized by the fact that the semistarved and
control animals display similar body weight (Fig. 1A) and
dry lean body mass (Fig. 1C), but compared with control
rats, the semistarved animals have 50% less fat mass (8 vs.
15.7 g, P  0.001) (Fig. 1D) and higher body water content
(155 vs. 148 g, P  0.01). Between days 0 and 15 of
refeeding on an isocaloric food intake relative to the
controls (Fig. 1B), the refed rats gained fat at a rate that is
about two times greater than that of controls (Fig. 1D),
whereas during days 15–20, both groups display similar
rate of fat gain. This enhanced efﬁciency of catch-up fat
during days 0–15 contrasts with no differences in lean
body mass gain (Fig. 1C). GTT conducted on days 8 and 9
of refeeding show no between-group differences in glu-
cose homeostasis (Fig. 1E) but reveal plasma insulin
concentrations after the glucose load that are clearly
higher in refed than in control animals (P  0.01 by
ANOVA test) (Fig. 1F).
Adipocyte number and size. The data on adipocyte cell
size distribution (Fig. 2A, left panel), mean adipocyte
diameter (Fig. 2D), and adipocyte cell number (Fig. 2C)
from epididymal WAT (EWAT) are presented for refed and
control animals at different time points during the phase of
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FIG. 1. Hyperinsulinemia in our rat model of semistarvation-refeeding, in which the accelerated fat recovery (catch-up fat) results only from
diminished energy expenditure (suppressed thermogenesis) and not from hyperphagia. In this particular investigation here, body weight and body
composition (A, C, and D) were determined at day 0, 5, 10, 15, and 20 of refeeding, with both groups consuming isocaloric amount of standard
diet (B). The acceleration of fat mass but not that of lean mass (i.e., preferential catch-up fat) lasts for about 2 weeks. E and F: Shows the plasma
glucose and insulin concentrations before and for 2 h after an intraperitoneal injection of glucose (2 g/kg body wt); the test of glucose tolerance
was performed on days 8 and 9 of refeeding. All values are means  SE (n  6); **P < 0.01; ***P < 0.001.
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ing to day 0 of refeeding), the weight of EWAT in semi-
starved animals is found to be signiﬁcantly lower than in
controls (Fig. 2B) and is associated with a signiﬁcant
shift-to-the-left of adipocyte diameter distribution (P 
0.001) and hence reduction in average adipocyte diameter,
without a signiﬁcant reduction in adipocyte cell number
(Fig. 2C). During the ﬁrst 15 days of isocaloric refeeding,
EWAT weight increases faster in refed than in control
groups (Fig. 2B), and the rate at which adipocyte cell
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FIG. 2. EWAT morphometry showing the frequency distribution curves for adipocyte cell diameter (A), the EWAT pad weight (B), the total
adipocyte cell number per EWAT pad (C), and the mean adipocyte diameter (D) in refed (RF) or control (C) animals at the end of semistarvation
(day 0) and days 5, 10, and 15 of isocaloric refeeding. Values are means  SE (n  6). Statistical analysis for differences in refed and controls
for adipocyte diameter distribution curves were performed by Kolmogorov-Smirnov tests, while between-group differences across time in EWAT
pad weight, adipocyte number, and mean adipocyte diameter were determined by regression analysis and comparison of slopes. The regression
coefﬁcients (r
2) of the regression lines in B–D are as follows. B: r
2  0.64 and 0.93 for control and refed, respectively. C: r
2  0.52 and 0.90 for
control and refed, respectively. D: r
2  0.47 and 0.71 for control and refed, respectively. In B–D, the above-mentioned r
2 values are statistically
signiﬁcant (P < 0.01).
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in refed than in control groups, as indicated by statistical
comparisons of their slopes of regression (Fig. 2C). Adi-
pocyte diameter remains signiﬁcantly lower in EWAT from
refed animals than in controls on day 5 and on day 10 (Fig.
2A and D) and only exceeded those of controls at day 15.
Thus, the recovery of adipose tissue, even in the absence
of hyperphagia, is accompanied by an increase in adipo-
cyte number, while the adipocyte diameter remains lower
in refed than in control animals during the dynamic phase
of catch-up fat, lasting for at least 10 days in this study.
Adipose tissue FAS activity. The data on FAS activity in
EWAT on days 0, 5, 10, and 15 of refeeding are shown in
Fig. 3. At the end of semistarvation (day 0), the activity of
FAS is found to be lower than in controls by 30% (P 
0.05) but overshoots above control upon refeeding. It is
signiﬁcantly higher in refed animals than in controls on
d a y5( 60%, P  0.01) and on day 10 (25%, P  0.05),
whereas on day 15, there are no longer signiﬁcant differ-
ences between refed and controls.
Adipose fatty acid composition. The data on the fatty
acid proﬁle of the triglyceride and phospholipid fractions
obtained from EWAT of animals on days 8 and 9 of
refeeding are presented in Fig. 4. In the triglyceride
fraction (Fig. 4A), the proportion of SFAs is signiﬁcantly
higher (P  0.01) in refed than in control animals, while
the proportion of PUFAs, as well as the PUFA-to-SFA ratio
are signiﬁcantly lower (P  0.001) in refed than in control
animals. By contrast, the proportions of SFAs, monoun-
saturated fatty acids (MUFAs), total PUFAs, and the
PUFA-to-SFA ratio in the phospholipid fraction (Fig. 4B)
are not different in EWAT from refed and control groups.
Adipose insulin signaling. To assess proximal insulin
signaling in adipose tissue, we measured IRS-1–associated
PI3K activity in EWAT from refed and control animals
after in vivo administration of insulin or saline control on
days 8 and 9 of refeeding. The results, presented in Fig. 5A,
show that PI3K activity is marginally higher in refed than
in control animals (overall group effect by two-factor
ANOVA, i.e., refed versus control: P  0.045), with post
hoc pairwise comparisons by unpaired t test indicating
that between-group difference in insulin-stimulated PI3K
activity (12%, P  0.09) or in basal PI3K activity (31%,
P  0.07) failing to reach statistical signiﬁcance. Similar
lack of statistical signiﬁcance is also observed with other
pairwise comparison tests (e.g., Scheffe’s, Tukey). Further-
more, measurement of downstream signaling (Akt phos-
phorylation) (Fig. 5B) shows no statistically signiﬁcant
group effect by ANOVA. Similarly, there are no differences
between refed and controls in ERK phosphorylation (data
not shown). Taken together, these data on days 8 and 9 of
catch-up fat suggest that at the dose of insulin tested, there
is no signiﬁcant difference in the sensitivity of the insulin
receptor IRS-1/PI3K/Akt signaling pathway.
Analysis of early catch-up fat. We also investigated in
vivo insulinemic response to glucose, adipose tissue insu-
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the ﬁrst day of catch-up fat (20–23 h after the start of the
semistarvation-refeeding transition). This time point was
chosen to be as close as possible to the initial process of
catch-up fat, while minimizing the gorging effects that
typically occur at the onset of refeeding. This was
achieved by providing the ﬁrst day’s refeeding diet in three
equal parts at 1500, 1900, and 2300 h during this transition,
with all food removed at 0700 h the next day and GTT
measurements starting 4 h later. As shown in Fig. 6A and
B, refed and control rats display similar glucose tolerance,
but the hyperinsulinemic response to the glucose load is
already present within day 1 of refeeding. Furthermore, we
found that on day 1 of refeeding, FAS activity was higher
in refed than in control animals 2 h after the glucose load
but not in saline controls (Fig. 6C). FAS activity 2 h after
the glucose load was also found to correlate positively
with both basal and postglucose insulin levels, with the
strongest correlations observed with the 30-min (peak)
insulin values (r
2  0.5, P  0.02). To investigate postre-
ceptor events at this early stage of catch-up fat, we
measured Akt phosphorylation, ERK phosphorylation, and
GLUT4 protein expression in EWAT harvested from refed
and control rats after injection of insulin or saline. The
results (Fig. 6D) did not reveal any difference in these
postreceptor events.
Induction of genes implicated in lipogenesis and
adipogenesis. We performed a detailed time course of the
expression of genes involved in lipogenesis (GLUT4, FAS,
and SREBP1c) and in adipogenesis (PPAR and CEBP).
The data in Fig. 7 show that the expression of these genes
are all rapidly induced within day 1 of refeeding relative to
semistarvation (day 0), with FAS expression signiﬁcantly
exceeding fed control values on this ﬁrst day of refeeding.
By day 3 of refeeding, all these genes for lipogenesis and
adipogenesis were upregulated relative to fed controls.
These inductions were still present after 9 days of catch-up
fat (P  0.01). By contrast, whereas the gene expression
of steoryl CoA desaturase 1 (SCD1) was rapidly induced
upon refeeding (relative to semistarvation), SCD1
mRNA levels were similar in refed and controls during
catch-up fat.
DISCUSSION
Using a rat model of semistarvation-refeeding in which,
from a perspective of energy balance, catch-up fat results
solely from lower energy expenditure (and not from
hyperphagia), we previously reported that during catch-up
fat, the in vivo glucose utilization, under insulin stimula-
tion, is diminished in skeletal muscle but enhanced in
WAT (13). The studies reported here suggest that this
enhanced capacity for glucose utilization in WAT during
catch-up fat is associated with 1) adipose tissue hyperpla-
sia and controlled hypertrophic growth, with adipocyte
size remaining signiﬁcantly smaller than controls; 2)a n
early and sustained enhancement in the capacity for
lipogenesis, in parallel to glucose-induced hyperinsulin-
emia and preserved proximal insulin signaling; and 3)a n
increase in the proportion of SFAs speciﬁcally in the
triglyceride (storage) fraction of WAT but not in the
phospholipids (membrane) component. Taken together,
these ﬁndings during catch-up fat underscore adipose
tissue plasticity in favor of an enhanced glucose ﬂux
toward fat storage in WAT and suggests that hyperinsulin-
emia might play a major role in the intitiation and promo-
tion of catch-up fat.
Adipose tissue morphometry. An inverse relationship
between adipocyte size and insulin-stimulated glucose
utilization is well established (18–22) and is directly
supported by in vitro studies (20,21) comparing large and
small adipocytes isolated from animals varying in size or
by comparing adipocytes varying in size from the same
animal (36). While the mechanisms of enhanced insulin
sensitivity pertaining to glucose uptake in small adipo-
cytes are poorly understood, they have often been linked
to an increase in the number of adipocytes and to en-
hanced adipogenesis (37). Consequently, the question
arose whether the enhanced in vivo insulin-mediated
glucose utilization in WAT found in our rat model of
catch-up fat (13) could also be related to the progressive
recovery of adipocyte size accompanied by an increase in
the number of adipocytes. The results presented here
show that adipocyte size, which is lower at the end of
semistarvation, remains smaller in refed animals than in
controls for at least 10 days of refeeding (Fig. 2A). This
lower adipocyte size during catch-up fat can in part be
explained by enhanced adipogenesis as evidenced from
the faster increase in adipocyte number, together with the
upregulation of PPAR and CEBP gene expression.
While these observations are consistent with several stud-
ies (38–41) describing WAT hyperplasia during refeeding
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FIG. 5. PI3K activity and Akt phosphorylation in epididymal fat pads in
response to either an acute bolus of intravenous administration of 10
units/kg of insulin (f) or a similar volume of saline () in refed (RF)
and control (C) groups on days 8 and 9 of refeeding. Values are
means  SE (n  6); statistical signiﬁcance of differences is indicated
as follows: @, effect of group (C versus RF); #effect of treatment
(hormone versus saline), as assessed by ANOVA. ###P < 0.001. Post
hoc between-group comparison treated with either saline or insulin
was performed by unpaired t test.
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demonstrate for the ﬁrst time that hyperphagia is not a
requirement for the induction of hyperplasia in response
to refeeding after growth arrest.
Adipose tissue de novo lipogenesis and fatty acid
proﬁling. The present studies showing that the adipose
tissue of refed animals display marked increases in FAS
activity and in the expression of key genes implicated in de
novo lipogenesis (GLUT4, SREBP1c, and FAS) are also
consistent with our previous demonstration of catch-up fat
as a state of increased insulin-mediated glucose utilization
in WAT (13). In contrast to the marked upregulation of de
novo lipogenic genes in WAT, however, the expression of
SCD1, the enzyme that catalyzes desaturation of SFAs to
monounsaturates, was not found to differ from that of
controls during catch-up fat. The enhancement of de novo
lipogenesis (relative to fed controls) without a parallel
increase in SCD1-induced desaturation could explain the
increase in the proportion of SFAs in the triglyceride lipid
fraction of adipose tissue during catch-up fat.
Adipose tissue de novo lipogenesis versus insulin
signaling. To test whether the increased lipogenesis and
glucose uptake in WAT observed during catch up-fat
depend on increased insulin sensitivity, we measured
proximal-insulin signaling following in vivo administration
of an insulin bolus on days 8 and 9 of refeeding. Measure-
ments of IRS-1–associated PI3K activity, AKT, and ERK
phosphorylation revealed a small statistically signiﬁcant
induction of IRS-1–associated PI3K activity during
catch-up fat, which, however, was not reﬂected in an
increased AKT phosphorylation or in ERK activation.
Although these results show only a marginal increase in
insulin signaling, it is important to emphasize that insulin
signaling is clearly not impaired, which is in sharp contrast
to the diminished PI3K activity in skeletal muscle obtained
from the same animals (15). Furthermore, unlike in skel-
etal muscle, where the insulin-resistant state can also be
associated with a decreased ratio of PUFA to SFA in the
phospholipid fraction (33), the data presented here on
adipose tissue show no such alterations in phospholipids
composition. These ﬁndings of differential regulation of
PI3K signaling and phospholipid composition in skeletal
muscle and adipose tissue are in line with the previously
reported studies of hyperinsulinemic-euglycemic clamps
(13), showing that glucose uptake is reduced in skeletal
muscle and enhanced in WAT during catch-up fat.
Whether adipose tissue reprogramming precedes or is
consequential to skeletal muscle insulin resistance is not
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is already evident on day 1 of refeeding, as judged by a
higher insulin response curve but normal glucose toler-
ance in refed animals relative to controls following admin-
istration of a glucose load (Fig. 6). Whether this
hyperinsulinemia can be explained entirely by peripheral
muscle insulin resistance or whether it may also be
contributed by pancreatic -cell hyperresponsiveness to
glucose is not known and is an interesting avenue for
future investigations. Nonetheless, the data obtained here
on day 1 of catch-up fat showing rapid induction in the
expression of genes controlling de novo lipogenesis in
WAT concomitant to a state of whole-body insulin resis-
tance suggest that hyperinsulinemia is an early event and
could therefore be a causal factor in the induction of de
novo lipogenesis in adipose tissue at the onset of refeed-
ing. As this hyperinsulemia persists during the course of
catch-up fat, it may also be important in maintaining the
high rate of de novo lipogenesis, as reﬂected by the
marked upregulation of lipogenic genes and/or high FAS
activity between days 3 and 10 of refeeding. However,
while increased insulin is undeniably a major factor in
initiating and sustaining enhancing glucose uptake and de
novo lipogenesis, the results of our previous hyperinsu-
linemic-euglycemic clamp studies (13) showing enhanced
glucose utilization in adipose tissue on day 7 of catch-up
fat implies increased insulin-dependent glucose utilization
by adipocytes for the same insulin stimulation. Conse-
quently, it can be speculated that the marked increases in
de novo lipogenic capacity observed here between days 3
and 10 of catch up fat could also be contributing to the
increased glucose uptake in adipose tissue. This concept,
which embodies interactions between insulin-stimulated
glucose uptake and de novo lipogenesis in adipose tissue
(depicted in Fig. 8), is consistent with studies showing that
pharmacological inhibitors of de novo lipogenesis de-
crease the ability of insulin to stimulate both the pentose
shunt glucose oxidation and overall glucose utilization but
not Krebs cycle or glyceride-glycerol synthesis (18,20). In
other words, the increased demand in acetyl-CoA and
NADPH for lipogenesis would lead to enhanced glucose
metabolism through glycolysis and the pentose phosphate
pathway, thereby driving glucose inﬂux. These studies led
to the proposal that the enzymatic capacity for fatty acid
synthesis is an important factor in determining insulin-
stimulated glucose utilization in WAT (18,20).
Conclusions. We show here that the process of catch-up
fat involves an early and sustained induction of hyperin-
sulinemia, increased glucose ﬂux toward lipogenesis, in-
creased SFAs speciﬁcally channelled to the triglyceride
stores and not to membrane phospholipids and that the
recovery of adipocyte size is accompanied by enhanced
adipogenesis, thereby limiting adipocyte hypertrophy.
Such adipose tissue plasticity suggest that WAT plays an
active role in glucose redistribution toward catch-up fat
during catch-up growth. Impairment in adipose tissue
plasticity may underlie some of the pathophysiological
consequences of catch-up growth. Indeed, enhanced lipo-
genesis in the absence of hyperplasia was recently re-
ported in a murine model of postnatal catch-up growth
characterized by hypertrophic adipocytes and glucose
intolerance (42). However, as underscored by apparently
conﬂicting ﬁndings that postnatal catch-up growth after
protein malnutrition programs proliferation of preadipo-
cytes in rats (43), it is likely that genetics and epigenetics-
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adipose tissue plasticity during catch-up growth (44).
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